Engineered extracellular vesicles for immunotherapy of chronic lymphocytic leukemia (CLL)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Ludwig-Maximilians-Universität, Dissertation, 2017
- Keyword
-
Immunotherapy
Chronic lymphocytic leukemia
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (when)
-
2017
- Creator
-
Gärtner, Kathrin Christina
- Contributor
-
Mautner, Josef
- URN
-
urn:nbn:de:bvb:19-226574
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gärtner, Kathrin Christina
- Mautner, Josef
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Time of origin
- 2017
Other Objects (12)
Stromal cells support the survival of human primary chronic lymphocytic leukemia (CLL) cells through Lyn-driven extracellular vesicles
Optimization of adoptive immunotherapy with genetically engineered T cells
Metabolic alterations in T cells during the course of Chronic Lymphocytic Leukemia (CLL)
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
Clonality analysis in B-cell chronic lymphocytic leukemia (B-CLL) associated with Richter's syndrome
Whole exome sequencing of chronic lymphocytic leukemia (CLL) : extending the number of recurrently mutated genes in CLL and detailed analysis of the putative CLL driver mutations in XPO1
From Theory to Therapy: The Advancements of Extracellular Vesicles in Immunotherapy
Optimization of engineered T cells for the use in melanoma immunotherapy
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Elucidation of the epigenetic code of the chromosomal region 13q14.3 in chronic lymphocytic leukemia (CLL)
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Optimized xenograft protocol for Chronic Lymphocytic Leukemia results in high engraftment efficiency for all CLL subgroups
Stromal cells support the survival of human primary chronic lymphocytic leukemia (CLL) cells through Lyn-driven extracellular vesicles
Optimization of adoptive immunotherapy with genetically engineered T cells
Metabolic alterations in T cells during the course of Chronic Lymphocytic Leukemia (CLL)
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
Clonality analysis in B-cell chronic lymphocytic leukemia (B-CLL) associated with Richter's syndrome
Whole exome sequencing of chronic lymphocytic leukemia (CLL) : extending the number of recurrently mutated genes in CLL and detailed analysis of the putative CLL driver mutations in XPO1
From Theory to Therapy: The Advancements of Extracellular Vesicles in Immunotherapy
Optimization of engineered T cells for the use in melanoma immunotherapy
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Elucidation of the epigenetic code of the chromosomal region 13q14.3 in chronic lymphocytic leukemia (CLL)
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Optimized xenograft protocol for Chronic Lymphocytic Leukemia results in high engraftment efficiency for all CLL subgroups
Stromal cells support the survival of human primary chronic lymphocytic leukemia (CLL) cells through Lyn-driven extracellular vesicles
Optimization of adoptive immunotherapy with genetically engineered T cells
Metabolic alterations in T cells during the course of Chronic Lymphocytic Leukemia (CLL)
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
Clonality analysis in B-cell chronic lymphocytic leukemia (B-CLL) associated with Richter's syndrome
Whole exome sequencing of chronic lymphocytic leukemia (CLL) : extending the number of recurrently mutated genes in CLL and detailed analysis of the putative CLL driver mutations in XPO1
From Theory to Therapy: The Advancements of Extracellular Vesicles in Immunotherapy
Optimization of engineered T cells for the use in melanoma immunotherapy
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Elucidation of the epigenetic code of the chromosomal region 13q14.3 in chronic lymphocytic leukemia (CLL)
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy